Hemogenyx Pharmaceuticals Plc Stock Debt To Equity
| HEMO Stock | 392.50 7.50 1.87% |
Hemogenyx Pharmaceuticals PLC fundamentals help investors to digest information that contributes to Hemogenyx Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Hemogenyx Stock. The fundamental analysis module provides a way to measure Hemogenyx Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Hemogenyx Pharmaceuticals stock.
Hemogenyx | Debt To Equity |
Hemogenyx Pharmaceuticals PLC Company Debt To Equity Analysis
Hemogenyx Pharmaceuticals' Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
| Competition |
Hemogenyx Total Stockholder Equity
Total Stockholder Equity |
|
According to the company disclosure, Hemogenyx Pharmaceuticals PLC has a Debt To Equity of 0.0%. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United Kingdom stocks average (which is currently at 0.0).
Did you try this?
Run Portfolio Manager Now
Portfolio ManagerState of the art Portfolio Manager to monitor and improve performance of your invested capital |
| All Next | Launch Module |
Hemogenyx Fundamentals
| Return On Equity | -1.56 | ||||
| Return On Asset | -0.38 | ||||
| Current Valuation | 14.72 M | ||||
| Shares Outstanding | 3.5 M | ||||
| Shares Owned By Insiders | 10.27 % | ||||
| Shares Owned By Institutions | 0.79 % | ||||
| Price To Book | 4.43 X | ||||
| EBITDA | (5.73 M) | ||||
| Net Income | (6.69 M) | ||||
| Total Debt | 2.95 M | ||||
| Book Value Per Share | 0 X | ||||
| Cash Flow From Operations | (6.11 M) | ||||
| Earnings Per Share | (2.00) X | ||||
| Number Of Employees | 17 | ||||
| Beta | 3.26 | ||||
| Market Capitalization | 14.02 M | ||||
| Total Asset | 6.11 M | ||||
| Retained Earnings | (23.8 M) | ||||
| Working Capital | 1.52 M | ||||
| Net Asset | 6.11 M |
About Hemogenyx Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Hemogenyx Pharmaceuticals PLC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Hemogenyx Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Hemogenyx Pharmaceuticals PLC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin |
Additional Tools for Hemogenyx Stock Analysis
When running Hemogenyx Pharmaceuticals' price analysis, check to measure Hemogenyx Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hemogenyx Pharmaceuticals is operating at the current time. Most of Hemogenyx Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Hemogenyx Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hemogenyx Pharmaceuticals' price. Additionally, you may evaluate how the addition of Hemogenyx Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.